CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- 4 Open-market sale Chairman, CEO sold 120,173 shares at an average $2.86 ($344,084)
- 4 Open-market buy Director bought 498 shares at $2.00 ($996)
- 4 Open-market sale Chairman, CEO sold 574,106 shares at an average $2.35 ($1,350,894)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 448 shares at $2.23 ($999)
- 4 Open-market buy Director bought 379 shares at $2.64 ($1,001)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale VP Product Develop sold 15,000 shares at $2.82 ($42,300)
- 4 Open-market sale Chairman and CEO sold 374,100 shares at an average $2.96 ($1,106,656)
- 4 Open-market buy Director bought 356 shares at $2.81 ($1,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 96 shares at $2.60 ($250)
- 4 Open-market buy Director bought 227 shares at $1.10 ($250)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 262 shares at $0.95 ($249)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 30 of 32 · 637 filings